The Orthopaedic Device Infection Network (ODIN): Building an Evidence Base for the Treatment of Periprosthetic Joint Infection through International Collaboration

Periprosthetic joint infections (PJI) are associated with substantial morbidity, affecting between 1 and 2% of patients undergoing a primary joint arthroplasty and approximately 7% of patients undergoing an aseptic joint revision [1]. Management of this condition typically requires prolonged hospital stays, multiple surgical procedures, and long-term antibiotic therapy. Such intensive management is associated with adverse mental health outcomes [2], reductions in overall quality of life [3], and high rates of morbidity [4, 5].